Skip to main content

Table 1 Tumor stage of MCC patients, as assessed by SSTR-PET and CT

From: Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging

No. SSTR-PET CT Up-staging by SSTR-PET Change of the therapeutic management due to SSTR-PET
1 IA* IA* No -
2 IA* IA* No -
3 IA IA No -
4 IA* IA* No -
5 IA* IA* No -
6 IA* IA* No Parotid surgery (Warthin tumor)
7 IIIA* IIIA* No -
8 IIIB IIIB No -
9 IIIB IIIB No -
10 IIIB IIIB No -
11 IIIB IIIB* No -
12 IIIB* IIIB* No -
13 IIIB* IIIB* No -
14 IV IV No Bisphosphonate Tx (bone mets)
15 IIIB IIC Yes Lymph node exstirpation (positive)
16 IV IV Yes -
17 IV IV No Bisphosphonate Tx (bone mets)
18 IV IV No -
19 IV IV No -
20 IV IV Yes -
21 IV IV No -
22 IV IV Yes -
23 IV IV No Bisphosphonate Tx (bone mets)
24 IV IV No -
  1. Clinical stage as indicated by SSTR-PET and CT. Asterisks (*) indicate patients free of disease. Upstaging by SSTR-PET as compared to conventional imaging. Change of management due to SSTR-PET was seen in 5 patients.